Tranylcypromine Sulfate (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Tranylcypromine Sulfate drug offered from Actavis Pharma, Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: tranylcypromine sulfate
SUBSTANCE NAME: TRANYLCYPROMINE SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2016-02-05
END MARKETING DATE: 0000-00-00


Tranylcypromine Sulfate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTranylcypromine Sulfate from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2016-02-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-5590_50ad0c27-788d-4914-a28b-e19ae8a54ebd
PRODUCT NDC: 0591-5590
APPLICATION NUMBER: NDA012342

Other TRANYLCYPROMINE SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Tranylcypromine Sulfate
Concordia Pharmaceuticals Inc.PARNATE
Golden State Medical Supply, Inc.Tranylcypromine Sulfate
Par Pharmaceutical, Inc.Tranylcypromine Sulfate
Rising Pharmaceuticals, Inc.Tranylcypromine Sulfate